Skip to main content
Gujarat Ambuja Exports Ltd. logo

Gujarat Ambuja Exports Ltd. — Investor Relations & Filings

Ticker · GAEL ISIN · INE036B01030 LEI · 335800M9TVMR5FIXZ129 BSE.NS Manufacturing
Filings indexed 964 across all filing types
Latest filing 2025-04-29 Regulatory Filings
Country IN India
Listing BSE.NS GAEL

About Gujarat Ambuja Exports Ltd.

https://www.ambujagroup.com

Gujarat Ambuja Exports Ltd. is an agro-processing organization specializing in the manufacturing of corn-based starch derivatives, soy products, and cotton yarn. The company operates integrated processing facilities to produce liquid glucose, sorbitol, maltodextrin, and dextrose monohydrate, serving the food, pharmaceutical, and paper sectors. Its soy division focuses on de-oiled cakes, refined soy oil, and lecithin for the animal feed and human nutrition markets. GAEL maintains an extensive global export footprint, providing high-volume industrial ingredients that meet international quality standards. The company leverages large-scale production capabilities to supply diverse applications in the textile and healthcare industries, emphasizing efficiency and consistency across its product portfolio.

Recent filings

Filing Released Lang Actions
Updates
Regulatory Filings Classification · 95% confidence The document is a disclosure letter addressed to stock exchanges regarding compliance with SEBI circulars on fund raising by issuance of debt securities by large corporates. It states that the company is not a large corporate for the financial years ended March 31, 2024 and March 31, 2025, and thus the filing requirement is not applicable. The document includes a confirmation and initial disclosure in a prescribed format but does not contain financial statements or detailed financial analysis. It is a regulatory compliance disclosure related to capital raising but does not report on actual financing activity or results. The document length is short (3071 characters) and it is essentially an official regulatory disclosure letter. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement and compliance document rather than a Capital/Financing Update (CAP) or other report type.
2025-04-29 English
Disclosure under SEBI Takeover Regulations
Regulatory Filings
2025-04-15 English
Change in Management
Regulatory Filings
2025-04-07 English
Disclosure under SEBI Takeover Regulations
Regulatory Filings
2025-04-04 English
Disclosure under SEBI Takeover Regulations
Regulatory Filings
2025-04-04 English
Disclosure under SEBI Takeover Regulations
Regulatory Filings
2025-04-04 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.